NORDBIOTIC Trademark

Trademark Overview

On Monday, December 13, 2021, a trademark application was filed for NORDBIOTIC with the United States Patent and Trademark Office. The USPTO has given the NORDBIOTIC trademark a serial number of 79331960. The federal status of this trademark filing is REGISTERED as of Tuesday, February 20, 2024. This trademark is owned by NORDIC BIOTIC Sp. z o.o.. The NORDBIOTIC trademark is filed in the Pharmaceutical Products category with the following description:

Medicines for the treatment of gastrointestinal and digestive diseases; Medicines for the treatment of immune system-related diseases and disorders; Medicines for the treatment of cardiovascular diseases; Medicines for the treatment of mental health; Medicines for the treatment of bone diseases; Medicines for the treatment of endocrine diseases; Medicines for the treatment of diabetes; Medicines for the treatment of thyroid diseases; Medicines for the treatment of autoimmune diseases or disorders; Medicines for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric,and immune system-related diseases and disorders, all for human consumption; food supplements
nordbiotic

General Information

Serial Number79331960
Word MarkNORDBIOTIC
Filing DateMonday, December 13, 2021
Status700 - REGISTERED
Status DateTuesday, February 20, 2024
Registration Number7307187
Registration DateTuesday, February 20, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 5, 2023

Trademark Statements

Goods and ServicesMedicines for the treatment of gastrointestinal and digestive diseases; Medicines for the treatment of immune system-related diseases and disorders; Medicines for the treatment of cardiovascular diseases; Medicines for the treatment of mental health; Medicines for the treatment of bone diseases; Medicines for the treatment of endocrine diseases; Medicines for the treatment of diabetes; Medicines for the treatment of thyroid diseases; Medicines for the treatment of autoimmune diseases or disorders; Medicines for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric,and immune system-related diseases and disorders, all for human consumption; food supplements

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, January 29, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNORDIC BIOTIC Sp. z o.o.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressPL
Party NameNORDIC BIOTIC Sp. z o.o.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressPL
Party NameNORDIC BIOTIC Sp. z o.o.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressPL

Trademark Events

Event DateEvent Description
Tuesday, February 20, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, February 20, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, December 5, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 5, 2023PUBLISHED FOR OPPOSITION
Sunday, December 3, 2023NOTIFICATION PROCESSED BY IB
Wednesday, November 15, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 15, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 15, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 31, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 26, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 26, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 26, 2023ASSIGNED TO LIE
Friday, July 21, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, June 27, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, June 28, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Saturday, May 27, 2023NOTICE OF REVIVAL - E-MAILED
Saturday, May 27, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, May 27, 2023PETITION TO REVIVE-GRANTED
Saturday, May 27, 2023TEAS PETITION TO REVIVE RECEIVED
Saturday, April 22, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Saturday, April 22, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, April 22, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Saturday, April 22, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, April 22, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, April 22, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 24, 2023NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, December 21, 2022REFUSAL PROCESSED BY IB
Saturday, November 26, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, November 26, 2022REFUSAL PROCESSED BY MPU
Wednesday, September 21, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, September 20, 2022NON-FINAL ACTION WRITTEN
Tuesday, September 20, 2022ASSIGNED TO EXAMINER
Saturday, May 21, 2022CHANGE OF NAME/ADDRESS REC'D FROM IB
Wednesday, February 2, 2022APPLICATION FILING RECEIPT MAILED
Saturday, January 29, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 27, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

nordbiotic treatment medicines diseases disorders cardiovascular endocrine related gastrointestinal immune system